Assignee
ONTARIO INC 1149336
CA·13 granted patents·5 pending applications·800 citations·filing 1995–2015
Top patents by PatentIndex Score
18 records- 0197US5846937AMethod of using exendin and GLP-1 to affect the central nervous systemONTARIO INC 1149336·Filed 1997·Granted Dec 8, 1998·113 cites·10 claims
- 0296US7049284B2Glucagon-like peptide-2 and its therapeutic useONTARIO INC 1149336·Filed 2002·Granted May 23, 2006·62 cites·3 claims
- 0396US5834428AGlucagon-like peptide-2 and its therapeutic useONTARIO INC 1149336·Filed 1996·Granted Nov 10, 1998·158 cites·16 claims
- 0495US6586399B1Methods of enhancing functioning of the large intestineONTARIO INC 1149336·Filed 2000·Granted Jul 1, 2003·50 cites·16 claims
- 0592US5990077AGlucagon-like peptide-2 and its therapeutic useONTARIO INC 1149336·Filed 1995·Granted Nov 23, 1999·109 cites·80 claims
- 0691US7176182B2Methods of enhancing functioning of the large intestineONTARIO INC 1149336·Filed 2003·Granted Feb 13, 2007·23 cites·3 claims
- 0790US7960344B2Methods of enhancing functioning of the large intestineONTARIO INC 1149336·Filed 2009·Granted Jun 14, 2011·7 cites·14 claims
- 0889US6051557AMethods of enhancing functioning of the upper gastrointestinal tractONTARIO INC 1149336·Filed 1998·Granted Apr 18, 2000·88 cites·48 claims
- 0988US5952301ACompositions and methods for enhancing intestinal functionONTARIO INC 1149336·Filed 1996·Granted Sep 14, 1999·76 cites·7 claims
- 1086US6297214B1Methods of enhancing functioning of the large intestineONTARIO INC 1149336·Filed 1998·Granted Oct 2, 2001·37 cites·20 claims
- 1183US5994500AAntagonists of intestinotrophic GLP-2 peptidesONTARIO INC 1149336·Filed 1996·Granted Nov 30, 1999·49 cites·15 claims
- 1274US6489295B1Antagonists of intestinotrophic GLP-2 peptidesONTARIO INC 1149336·Filed 1999·Granted Dec 3, 2002·28 cites·18 claims
- 1366US2014213518A1Methods of enhancing functioning of the large intestineONTARIO INC 1149336·Filed 2013·Application pending·0 cites
- 1459US2015290295A1Methods of enhancing functioning of the large intestineONTARIO INC 1149336·Filed 2015·Application pending·0 cites
- 1556US7862824B2Enhancement of GLP-2 activity of suppressing appetiteONTARIO INC 1149336·Filed 2004·Granted Jan 4, 2011·0 cites·4 claims
- 1654US2011223108A1Glucagon-like peptide-2 and its therapeutic useONTARIO INC 1149336·Filed 2010·Application pending·0 cites
- 1751US2003109449A1Antagonists of intestinotrophic GLP-2 peptidesONTARIO INC 1149336·Filed 2002·Application pending·0 cites
- 1845US2002123461A1Enhancement of GLP-2 activityONTARIO INC 1149336·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ONTARIO INC 1149336 files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →